back to all entries

Fibroid Research & Education Act Reintroduced to Congress.

August 07,2023

Congresswoman Yvette Clarke (D-NY) and her colleagues Bonnie Watson Coleman (D-NJ) and Robin Kelly (D-IL) have reintroduced the Stephanie Tubbs Jones Uterine Fibroid Research and Education Act to the House of Representatives. The bill was named to honor the late Ohio congresswoman Stephanie Tubbs Jones, who first presented the legislation more than two decades ago. The proposed legislation would expand research and public education programs about the symptoms and treatment of uterine fibroids. In a bipartisan effort, Cory Booker (D-NJ) and Shelley Moore Capito (R-WV) reintroduced the bill to Senate.

Fibroids are benign (non-cancerous) tumors that develop on the muscle tissue of the uterus. They are called leiomyomas or myomas. Uterine fibroid disease impacts approximately 26 million women in the USA. Some women do not have symptoms. However, others experience symptoms such as painful intercourse, heavy prolonged periods, painful cramps, pregnancy loss, or even infertility. African American women experience the condition earlier, more frequently, and with more severe symptoms.  

The bill also emphasizes the importance of better patient and provider education regarding the increased risk for fibroids that women of color face. The law would specifically: 

  • Establish NIH research funding of $150 million over five years. 
  • Include an expansion of the CMS chronic diseases database, including information on the services available to patients with fibroids.
  • Develop a CDC public education campaign.
  • Give healthcare providers access to information on fibroids created by HRSA, including details on non-surgical treatment alternatives.

The proposal estimates the yearly financial burden of uterine fibroids on the American healthcare system to be $6 to over $34 billion. Uterine fibroids are the leading cause of hysterectomies in the United States. According to the National Institutes of Health, uterine fibroids affect 75 percent of women of reproductive age. 

The late Ohio congresswoman Stephanie Tubbs Jones first presented the legislation more than two decades ago

About Fibroid Fighters

Fibroid Fighters is a public welfare organization created to advance the cause of women’s health and the safe and effective treatment of uterine fibroids.

Fibroid Fighters’ mission is to:

  • Inform – Arm women with knowledge about fibroid symptoms and treatments so they can take an active role in their care.
  • Research –  Encourage research that improves fibroid treatment for earlier detection, better care, and better results.
  • Educate –  Increase public awareness of uterine fibroids’ economic, social, and health effects.

Do you suspect you may have fibroids? Check your symptoms here.

Sign up for our newsletter.

Other Posts

Fibroid Research Breakthrough Linking Genetic Changes to Abnormal Uterine Bleeding
08/22/25

New Research Reveals Genetic Clues Behind Heavy Menstrual Bleeding

A groundbreaking study published in Communications Medicine is shedding new light on the biology of uterine fibroids and their link to heavy menstrual bleeding. Affecting up to 80% of women

08/14/25

Why Are Uterine Fibroids Rising Among Young Indian Women?

A growing trend shows uterine fibroids increasingly being diagnosed in Indian women in their 20s and 30s, especially in urban areas. According to The Daily Jagran, experts point to a

Fibroid Research Federal
08/13/25

U.S. Rep. Shontel Brown Champions Federal Push for Uterine Fibroid Research

Congresswoman Shontel Brown (D‑OH) has reintroduced the U-FIGHT Act (Uterine Fibroid Intervention and Gynecological Health and Treatment Act), designed to establish a federal grant program under the Department of Health